Ranelic Acid

CHEMBL2107175 Phase 4 Aprobado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

342.3 g/mol

LogP

0.3

Phase

4

Ranelic acid is the parent acid component of strontium ranelate, a dual-mechanism osteoporosis treatment where strontium ions partially substitute for calcium in hydroxyapatite crystal while simultaneously stimulating bone formation and inhibiting bone resorption through interactions with the calcium-sensing receptor. Strontium ranelate (strontium plus ranelic acid) was used for the treatment of severe osteoporosis to reduce fracture risk.

Peso molecular

342,2800 g/mol

LogP

0,30

TPSA

204,00 Å²

Regla de cinco de Lipinski

Cumple

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

N#Cc1c(N(CC(=O)O)CC(=O)O)sc(C(=O)O)c1CC(=O)O

InChI

InChI=1S/C12H10N2O8S/c13-2-6-5(1-7(15)16)10(12(21)22)23-11(6)14(3-8(17)18)4-9(19)20/h1,3-4H2,(H,15,16)(H,17,18)(H,19,20)(H,21,22)

Molecular Formula

C12H10N2O8S

HBD / HBA

4 / 11

Enlaces Rotables

8

Átomos Pesados

23

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

Ranelic acid is the parent acid component of strontium ranelate, a dual-mechanism osteoporosis treatment where strontium ions partially substitute for calcium in hydroxyapatite crystal while simultaneously stimulating bone formation and inhibiting bone resorption through interactions with the calcium-sensing receptor. Strontium ranelate (strontium plus ranelic acid) was used for the treatment of severe osteoporosis to reduce fracture risk.

Yes, Ranelic Acid is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2107175. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 3052774. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

¿Busca información accesible para el paciente?

Ranelic Acid en PillFYI

Estructura

Datos Rápidos

Fórmula: C12H10N2O8S

Enlaces externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.